Global nutrition and health company dsm-firmenich reports a robust financial performance for 2024, highlighting strong growth in its Human Nutrition & Care (HNC) and its Animal Health & Nutrition (ANH) segments, the latter of which it plans to fully divest from this year. The company says it is focused on innovation and strategic restructuring.
